EUVIMEDEUVIMED entdecken
Crossref

Disruption of PCSK9 Suppresses Inflammation and Attenuates Abdominal Aortic Aneurysm Formation

Zekun Peng, Shuang-Jie Lv, Hong Chen iD, Haojie Rao iD, Ziyi Guo, Qing Wan iD, Jianfeng Yang iD, Yuze Zhang iD, De-Pei Liu iD, Hou-Zao Chen iD, Miao Wang iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2025

DOI: 10.1161/atvbaha.123.320391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Zekun Peng und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and …. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, Proprotein Convertase 9, Disease Models, Animal, Mice, Inbred C57BL. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Abdominal aortic aneurysm (AAA) is a chronic vascular inflammatory disease without effective medications. PCSK9 (proprotein convertase subtilisin/kexin 9), a serine protease from the proprotein convertase family, has recently been associated with AAA in human genome-wide association studies. However, its role in AAA is unknown. METHODS: Transcriptional and histological expression of PCSK9 was examined in AAA tissues and healthy controls. The impact of PCSK9 deletion and inhibition on AAA formation was assessed in mice with hyperlipidemia and Ang II (angiotensin II) overproduction. AAA lesion morphology was assessed by tissue staining. MMP (matrix metalloproteinase) activity was evaluated by gelatin zymography, and leukocyte-vessel wall interaction was monitored by intravital microscopy. RNA sequencing was used to characterize the downstream signaling of PCSK9. RESULTS: PCSK9 expression was upregulated and colocalized with macrophages in human and mouse AAAs. Pcsk9 deletion attenuated AAA formation, improved survival, and decreased systemic inflammation, without altering circulating cholesterol levels. Pcsk9 deficiency reduced aortic infiltration of macrophages and elastin degradation, without affecting vascular smooth muscle cell apoptosis and proliferation. Mechanistically, PCSK9 was essential in leukocyte-endothelium adhesion and expression of proinflammatory cytokines and MMP9 by macrophages. RNA sequencing of stimulated macrophages revealed that Pcsk9 deficiency upregulated histone deacetylase SIRT1 (sirtuin-1) and suppressed NF-κB (nuclear factor-κB) inflammatory signaling. SIRT1 inhibition attenuated the proinflammatory actions of PCSK9. Furthermore, administration of PCSK9 small interfering RNA or antibody constrained AAA formation/progression and inhibited vascular inflammation. CONCLUSIONS: PCSK9 critically mediates macrophage inflammation and elastin degradation, promoting AAA formation. PCSK9 inhibitors bear a promise to curtail AAA, beyond being used as cholesterol-lowering drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Aneurysm, AbdominalProprotein Convertase 9Disease Models, AnimalMice, Inbred C57BLAnimalsHumansMaleMiceSignal TransductionAorta, AbdominalSirtuin 1MacrophagesMatrix Metalloproteinase 9Angiotensin IIMice, KnockoutInflammationMyocytes, Smooth MuscleNF-kappa BCells, CulturedCase-Control StudiesPCSK9 Inhibitors

Stichwörter der Autor:innen

PCSK9aortic aneurysm, abdominalinflammationmacrophagessirtuin-1

Substanzen

Proprotein Convertase 9Pcsk9 protein, mousePCSK9 protein, humanSirtuin 1Matrix Metalloproteinase 9Sirt1 protein, mouseAngiotensin IINF-kappa BPCSK9 Inhibitors

Autor:innen und Institutionen

  • State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Xicheng District, Beijing, China (Z.P.,…
  • State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical C…
  • Clinical Pharmacology Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Xicheng District, Beijing, China (M.W.).
  • National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Fuwai Central-China Cardiov…

ORCID-Profile: Hong Chen, Haojie Rao, Qing Wan, Jianfeng Yang, Yuze Zhang, De-Pei Liu, Hou-Zao Chen, Miao Wang

Zitieren

APA

Peng, Z., Lv, S. J., Chen, H., Rao, H., Guo, Z., Wan, Q., Yang, J., Zhang, Y., Liu, D. P., Chen, H. Z., & Wang, M. (2025). Disruption of PCSK9 Suppresses Inflammation and Attenuates Abdominal Aortic Aneurysm Formation. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.123.320391

Vancouver

Peng Z, Lv SJ, Chen H, Rao H, Guo Z, Wan Q, et al. Disruption of PCSK9 Suppresses Inflammation and Attenuates Abdominal Aortic Aneurysm Formation. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.123.320391

BibTeX
@article{Peng2025,
  author = {Peng, Zekun and Lv, Shuang-Jie and Chen, Hong and Rao, Haojie and Guo, Ziyi and Wan, Qing and Yang, Jianfeng and Zhang, Yuze and Liu, De-Pei and Chen, Hou-Zao and Wang, Miao},
  title = {Disruption of PCSK9 Suppresses Inflammation and Attenuates Abdominal Aortic Aneurysm Formation},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2025},
  doi = {10.1161/atvbaha.123.320391}
}
Kostenlos starten →